News

Staff Spotlight: Vera George, BSN, RN

Clinical research is an integral part of developing, testing, and refining new therapies. As one of our Clinical Research Coordinators Vera George is responsible for making sure dozens of these studies at Duke run smoothly and efficiently. For this week’s “Spotlight” interview, George talks to us about the joys of helping current and future patients with myasthenia gravis, movement disorders, and other conditions.

Duke Neurology Research Round Up, March 2022


This February, new research from members of the Duke Neurology Department advanced our understanding of the treatment of stroke, brain tumors and amyotrophic lateral sclerosis (ALS) as well as the genetics and origins of Alzheimer’s disease. The 13 journal articles written or co-written by members of our faculty include publications in JAMA, Neurology, the British Medical Journal, and other publications. Read summaries of those studies, and find links to the original articles, in the paragraphs below.

 

Duke Neurology Research Round Up, February 2022

The first month of 2022 saw the publication of 18 new peer-reviewed journal articles from members of the Duke Neurology Department. Highlights include a new article in Lancet Neurology discussing the epidemiology, diagnostics, and  biomarkers of autoimmune neuromuscular junction disorders, case reports describing the progression and treatment options for rare neurological conditions, and a summary of how the first year of the COVID-19 pandemic affects neurology residency programs in the United States.

Duke Neurology Research Round Up, January 2022

Research authored by members of the Duke Neurology Department published during the final month of 2021 advanced our knowledge of stroke, epilepsy, dystonia, and other conditions.

Duke Neurology 2021: A year in review (part 2 of 2)

The second half of 2021 was as eventful as the first for the Duke Neurology Department. Story highlights from July through December of this year include our Leonard White, PhD, winning a national award for excellence in teaching, the founding of a joint Duke/UNC Alzheimer’s Disease Research Center, two of our hospitals receiving the American Heart Association/American Stroke Association’s highest award for quality stroke care, and the School of Medicine receiving  awards totaling $18 million to uncover the origins of Parkinson’s disease.

Plasma exchange therapy for Guillain-Barré helps woman make a drastic recovery

Over the course of a few days in late September of 2021, Carol Cerase of Lumberton, NC, experienced increasing weakness in her legs, trouble swallowing, and several falls. Doctors at her local hospital couldn’t find the cause, so they reached out to Duke Health’s neurology experts, who diagnosed Cerase with Guillain-Barré syndrome (GBS). Duke’s team recommended plasma exchange therapy to stop the disease’s progression and allow the nerves to heal. “I was lucky I got the treatment so fast,” said Cerase. “I think it saved me.”

Duke Neurology Research Round Up, November 2021

This October, members of the Duke Neurology Department contributed to 12 new peer-reviewed journal articles, advancing our understanding of Alzheimer’s disease, stroke, chronic pain, and other conditions. These articles include discussions of the best framework for neuroscience curricula for medical students, the discovery of an existing experimental drug which offers a new avenue for treating pain without potential addiction issues, and an examination of the viability of ketogenic diets as an alternative treatment for amyotrophic lateral sclerosis (ALS).

Duke Neurology Research Round Up, September 2021

Members of the Duke Neurology Department contributed to seventeen peer-reviewed research studies published this August. Members of the lab of Nicole Calakos, MD, PhD, discovered that a medication created to treat patients with HIV may help people with dystonia. New translational research provided the most accurate atlas of the mouse model to date and answered questions about late-onset Alzheimer’s disease.

Duke Neurology Research Round Up, August 2021

This July, new research from the Duke Neurology Department answered questions about the subcellular origins of itching, how COVID-19 is affecting people with amyotrophic lateral sclerosis, what factors influence people eligible for epilepsy surgery to move forward with the procedure and topics. The paragraphs below summarize the 11 articles appearing in peer-reviewed publications from our faculty, staff, and trainees. Check them out and find links to the original publications below.

Neuromuscular Disease